Writing assistance was utilized in the production of this manuscript. Cite this: Roflumilast: Systemic Therapy for Chronic Obstructive Pulmonary Disease - Medscape - Oct 01, 2008.

Panelists discuss how emerging, better-tolerated oral therapies for idiopathic pulmonary fibrosis (IPF) and progressive ...

For patients undergoing surgical procedures, there is no association between liberal preprocedural fasting policies and ...

Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced the receipt of an additional $50.0 ...

Only five days after FDA approval of Yutrepia, Liquidia announced its first commercial shipment of the therapy, making prescriptions available to patients at specialty pharmacies. “We have moved with ...

Serious conditions behind bloody cough symptoms revealed. Life-threatening diseases that cause alarming blood in cough ...

Previous knowledge on melatonin use for pulmonary arterial hypertension has primarily been gathered from animal studies, with ...

The latest research published in Genes & Diseases unveils groundbreaking insights into the role of the aging process and the ...

Dr. Kimberly Trotter distilled four high-impact disease clusters—gout, rheumatoid arthritis (RA), systemic lupus ...

Gunnarsson K, et al. Hematological malignancies in systemic sclerosis, a population-based nationwide register study. Presented at EULAR 2025; OP0221. DOI: 10.1136/annrheumdis-2025-eular.B444.

A string of dolphin deaths at one of its Florida locations forced a facility closure and sparked multiple investigations.